Clinical Trial Update: A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing SYMBICORT pMDI with Budesonide HFA pMDI in African American subjects with asthma has completed. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide HFA pMDI (budesonide)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2012-10-30